SEC
SlamSEC
SearchBrowseEarnings

Amneal Pharmaceuticals, Inc.

Nasdaq:AMRX
Pharmaceutical Preparations
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

9 shown
FiledDescription
2/3/26
1.012.03
Material Agreement · New Debt Obligation
→
8/1/25
1.012.03
Material Agreement · New Debt Obligation
→
11/14/23
1.012.03
Material Agreement · New Debt Obligation
→
10/17/23
1.01
Material Agreement
→
6/2/22
1.011.022.03
Material Agreement · Agreement Terminated · New Debt Obligation
→
1/5/22
1.01
Material Agreement
→
↓ 3 more

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products.

CEO
Patel Chintu
CFO
Konidaris Tasos